Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Here's Leo's comment on partnering from the June conference call. If it differs in any way from what SA published it's due to my having cleaned the transcript up while listening to the audio. I'm quoting from my corrected version of the SA transcript.

https://seekingalpha.com/article/4080068-innovation-pharmaceuticals-ipix-ceo-leo-ehrlich-q3-2017-results-earnings-call-transcript?part=single

Leo Ehrlich

Well we've been quite open in communicating that partnering is a primary strategic goal during 2017. Industrywide, it's a prime time as it becomes increasingly the case that most approved drugs move down the clinical path by smaller biotechs like ours rather than Big Pharma.

The thing is though bigger pharmas are increasingly under pressure to build value and that means aggressively looking outside their labs for innovative products. This actually touches on the previous question.

Companies will pay what the drug is worth to them. Our job when it comes to partnering is to get our pipeline far enough along to present positive datasets to several potential partners and go from there. That's the point we are at currently.

We had said that confidential disclosure agreements have been signed with several pharmas interested in our drug candidates; to some, they're interested in one compound. Others have requested information on a combination of Brilacidin and Kevetrin and Prurisol.

All the conversations have been productive and as we approach additional readouts, I'd imagine that they're only going to get more active. Active partnership versus acquisition on possible exits, we plan to keep an open mind should opportunities present themselves. It will be great to have the problem of evaluating various options regarding partnering for single or multiple indications, foreign or domestic, selling right, outright or any other scenario of partnering. We'll cross that bridge when we get to it with decisions made by our Board of Directors as it is their fiduciary duty to do what is best for our shareholders.

In the meantime, we can say that big pharma knows that we know there's tremendous value in our pipeline. They know that. We work daily to position our product to command the highest value. The good news is that data will start streaming in very shortly. The bottom line is assuming the data is in line with previous data or interim results, we feel there are opportunities for partnering.

In Reply to 'tryz'
Question to the real IPIX Shareholders : Do you believe or think that Leo and company would consider a formidable merger with any huge Bio-Pharma or being more selective in protecting our assets and future licenses and royalties longterm to there entire drug pipeline???.....thoughts gang,tryz